17 results
S-3
EX-1.2
GLUE
Monte Rosa Therapeutics Inc
1 Jul 22
Shelf registration
5:01pm
without limitation (i) all expenses incident to the issuance and delivery of the Shares (including all printing and engraving costs); (ii) all fees … fees incident to FINRA review, if any; (ix) the costs and expenses of the Company relating to investor presentations on any “road show” undertaken
10-K
2021 FY
EX-10.20
GLUE
Monte Rosa Therapeutics Inc
29 Mar 22
Annual report
4:15pm
of such sale against any (a) amounts due by Tenant to Landlord under this Lease and (b) any expenses incident to the removal, storage and sale … $2,000,000 per incident with a $4,000,000 policy aggregate and for a period of two (2) years thereafter.
(g) During all construction by Tenant
10-K
qnsk86vlqo9 5bb99hh4
29 Mar 22
Annual report
4:15pm
10-Q
vuxw15m526c
12 Aug 21
Quarterly report
4:22pm
424B4
0ksp35a6l3ix0s
25 Jun 21
Prospectus supplement with pricing info
6:08am
S-1/A
6fv d5cnx2r56c
9 Jun 21
IPO registration (amended)
4:51pm
S-1
EX-3.3
8mzivaq0hu3
4 Jun 21
IPO registration
9:07am
S-1
zlnozsqu 5bfqqiny04n
4 Jun 21
IPO registration
9:07am
DRS/A
sdl7kj u7di
21 May 21
Draft registration statement (amended)
12:00am
DRS
EX-3.3
j5dwj4 lp6ix22rc
19 Apr 21
Draft registration statement
12:00am
DRS
fyf16z2g5
19 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next